Overbought, market rolling, and big short interest.
Bottom line long-term is: Cologuard can't support this valuation.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
